MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on June 20, 2016. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on June 20, 2016. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on June 20, 2016. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Thrombin inhibition compared with other antithrombotic drugs in rats.
Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.
Pharmacologic implications of heparin interactions with other drugs.
Pharmacogenetics and oral antithrombotic drugs.
Antithrombotic drugs: part II.
Low dose heparin therapy: in vitro verification of antithrombotic effect.
[Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
Cinchona and Other Medical Drugs.
IIIa antagonists as antithrombotic drugs.
Anticoagulant and antithrombotic activity of heparin salts by intraduodenal route in rabbits.
[Comparison of the antithrombotic effects of heparin, enoxaparin and prostacycline in continuous hemofiltration].
Drugs vs. other therapies.
Intra-operative antithrombotic therapy with low molecular weight heparin in aortic surgery. How should heparin be administered?
Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfate.
Structure and biological activity of heparin and other glycosaminoglycans.
Antithrombotic therapy: new areas to understand efficacy and bleeding.
Control of angiogenesis by heparin and other sulfated polysaccharides.
(Systemic) phototoxicity of drugs and other xenobiotics.
Other targeted drugs in melanoma.
Interactions between oral contraceptives and other drugs.
New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.
Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.
Low-molecular-weight heparin and other new antithrombotic drugs.
The New England Journal of Medicine Downloaded from nejm.org on June 20, 2016. For personal use only. No other uses without permission. Copyright © 19...
591KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Thrombin inhibition compared with other antithrombotic drugs in rats.
Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.
Pharmacologic implications of heparin interactions with other drugs.
Pharmacogenetics and oral antithrombotic drugs.
Antithrombotic drugs: part II.
Low dose heparin therapy: in vitro verification of antithrombotic effect.
[Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
Cinchona and Other Medical Drugs.
IIIa antagonists as antithrombotic drugs.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms